No Relevant Pharmacokinetic (PK) Interaction between Rezafungin and Nine Probe Drugs: Results from a Drug-Drug Interaction (DDI) Study

被引：0
|
作者：
Ong, Voon [1 ]
Sandison, Taylor [1 ]
Flanagan, Shawn [1 ]
机构：
[1] Cidara Therapeut, San Diego, CA USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2019年 / 25卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
535
引用
收藏
页数：2
相关论文
共 50 条
  • [1] A drug-drug interaction (DDI) study between rezafungin and nine probe drugs show no relevant pharmacokinetic change
    Ong, Voon
    Boily, Michael
    Wong, Hong
    Sandison, Taylor
    Flanagan, Shawn
    BONE MARROW TRANSPLANTATION, 2019, 54 : 418 - 419
  • [2] PHARMACOKINETIC (PK) BASIS OF STATIN DRUG-DRUG INTERACTION (DDI) INFORMATION IN FDA LABELS
    Mease, J.
    Ramamoorthy, A.
    Yang, X.
    Madabushi, R.
    Fletcher, E. Pfuma
    Zineh, I.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 113 : S13 - S13
  • [3] No relevant pharmacokinetic drug-drug interaction between nintedanib and pirfenidone
    Richeldi, Luca
    Fletcher, Sophie
    Adamali, Huzaifa
    Chaudhuri, Nazia
    Wiebe, Sabrina
    Wind, Sven
    Hohl, Kathrin
    Baker, Andrew
    Schlenker-Herceg, Rozsa
    Stowasser, Susanne
    Maher, Toby M.
    EUROPEAN RESPIRATORY JOURNAL, 2019, 53 (01)
  • [4] Acute Leukaemia and Cancers Therapy Relevant Drug-Drug Interaction (DDI) due to the Pharmacokinetic Factors
    Li, F.
    Ji, M.
    Yang, X.
    Wei, R.
    Liu, Z.
    Zhang, Y.
    Zhang, L.
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S647 - S647
  • [5] Acute Myeloid Leukaemia Therapy Relevant Drug-Drug Interaction (DDI) Due to the Pharmacokinetic Factors
    Ji, Mu-Yuan
    Yang, Xiao-Mei
    Wei, Ruo-Ying
    Zhang, Yuan-Yuan
    Liu, Zhi-Juan
    Li, Fu
    LATIN AMERICAN JOURNAL OF PHARMACY, 2018, 37 (04): : 804 - 807
  • [6] No Relevant Pharmacokinetic Interaction Between Nintedanib and Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis (IPF): Results from a Drug-Drug Interaction Study
    Richeldi, L.
    Fletcher, S.
    Adamali, H.
    Chaudhuri, N.
    Wiebe, S.
    Wind, S.
    Hohl, K.
    Baker, A.
    Schlenker-Herceg, R.
    Stowasser, S.
    Maher, T. M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [7] Drug-Drug Interaction (DDI) of Eslicarbazepine Acetate with Antiepileptic Drugs
    Blum, David
    Nunes, Teresa
    Maier, Gary
    Versavel, Mark
    Zummo, Jacqueline
    Kharidia, Jahnavi
    Soares-da-Silva, Patricio
    NEUROLOGY, 2011, 76 (09) : A287 - A287
  • [8] Pharmacokinetic drug-drug interaction study between raltegravir and citalopram
    Blonk, Maren I.
    Langemeijer, Charlotte C. A.
    Colbers, Angela P. H.
    Hoogtanders, Karin E. J.
    van Schaik, Ron H. N.
    Schouwenberg, Bas J. J. W.
    ANTIVIRAL THERAPY, 2016, 21 (02) : 143 - 152
  • [9] Tumor Treatment Drugs-Related Drug-Drug Interaction (DDI) between Vismodegib and Irinotecan
    Yu, Jian
    Wang, Gui
    Jiang, Yang-Shen
    Jiang, Yuan
    Cao, Qiu-Ting
    Zhang, Xiao-Fei
    Han, Jing-Chun
    LATIN AMERICAN JOURNAL OF PHARMACY, 2017, 36 (09): : 1811 - 1815
  • [10] A drug-drug interaction (DDI) study to assess the effect of oral galeterone on the pharmacokinetics (PK) of oral midazolam
    Ferrante, Karen J.
    Jacoby, Douglas B.
    Sonnichsen, Daryl
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
12345